Ultrasound screening of fetuses at increased risk for Down syndrome: How many missed diagnoses?

Prenatal Diagnosis

Volumn 26, Issue 1, 2006, Pages 22-27

  Caughey, Aaron B ^a,b   Lyell, Deirdre J ^c   Washington, A Eugene ^a   Filly, Roy A ^a   Norton, Mary E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Down syndrome; Prenatal diagnosis; Ultrasound

Indexed keywords

ALPHA FETOPROTEIN;

AMNIOCENTESIS; ARTICLE; DIAGNOSTIC ACCURACY; DOWN SYNDROME; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FETUS; FETUS ECHOGRAPHY; HEALTH CARE POLICY; HIGH RISK PATIENT; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MATERNAL SERUM; MEDICAL DECISION MAKING; OUTCOMES RESEARCH; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SCREENING TEST; SECOND TRIMESTER PREGNANCY; SYSTEMATIC REVIEW; ULTRASOUND;

DECISION SUPPORT TECHNIQUES; DECISION TREES; DOWN SYNDROME; FEMALE; GENETIC COUNSELING; HUMANS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL;

EID: 31944449425     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1319     Document Type: Article

References (30)

1. Aitken DA, Wallace EM, Crossley JA, et al. 1996. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy. N Engl J Med 334: 1231-1236.
2. Benacerraf BR. 1996. Use of sonographic markers to determine the risk of Down syndrome in second-trimester fetuses. Radiology 201: 619-620.
3. Bromley B, Shipp TD, Benacerraf BR. 1999. Genetic sonogram scoring index: accuracy and clinical utility. J Ultrasound Med 18: 523-528.
4. California Department of Health Services. 1997. Prenatal Care Provider Handbook. Sacramento, CA.
5. Caughey AB, Lyell DJ, Filly R, Washington AE, Norton ME. 2001. The impact of the use of echogenic intracardiac focus as a screen for Down syndrome in women under the age of 35. Am J Obstet Gynecol 85: 1021-1027.
6. Corteville JE, Dicke JM, Crane JP. 1992. Fetal pyelectasis and Down syndrome: is genetic amniocentesis warranted? Obstet Gynecol 79: 770-772.
7. Cuckle HS, Wald NJ, Lindenbaum RH. 1984. Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome. Lancet 1(8383): 926-929.
8. DeVore GR. 2000. Trisomy 21: 91% detection rate using second-trimester ultrasound markers. Ultrasound Obstet Gynecol 16: 133-141.
9. Ewigman BG, Crane JP, Frigoletto FP, et al. 1993. Effect of prenatal ultrasound screening on perinatal outcome. N Engl J Med 329: 821-827.
10. Haddow JE, Kloza EM, Smith DE, Knight GJ. 1983. Data from an alphafetoprotein pilot screening program in Maine. Obstet Gynecol 62: 556-560.
11. Kuppermann M, Feeny D, Gates E, et al. 1999. Preferences of women facing a prenatal diagnostic choice: Long-term outcomes matter most. Prenat Diagn 19: 711-716.
12. Kuppermann M, Goldberg JD, Nease RF Jr, et al. 1999. Who should be offered prenatal diagnosis? The 35-year-old question. Am J Public Health 89: 160-163.
13. Kuppermann M, Nease RF, Learman LA, et al. 2000. Procedure-related miscarriages and Down syndrome affected births: Implications for prenatal testing based on women's preferences. Obstet Gynecol 96: 511-516.
14. Levine D, Mehta TS, Min KK, et al. 2000. Technical factors influencing sonographic visualization of fetal echogenic intracardiac foci. J Clin Ultrasound 28: 479-484.
15. Malone F, Nyberg DA, Vidaver J, et al. 2004. First and second trimester evaluation of risk (FASTER) trial: The role of second trimester genetic sonography. Am J Obstet Gynecol 191: S3.
16. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. 1984. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 148: 886-894.
17. National Institute of Child Health and Human Development. Antenatal Diagnosis: Report of a Consensus Development Conference. US Dept of Health, Education and Welfare, Public Health Service, National Institutes of Health: 1979.
18. NICHD National Registry for Amniocentesis Study Group. 1976. Midtrimester amniocentesis for prenatal diagnosis. Safety and accuracy. JAMA 236: 1471-1476.
19. Nyberg DA, Souter VL. 2001. Sonographic markers of fetal trisomies: second trimester. J Ultrasound Med 20: 655-674.
20. Nyberg DA, Resta RG, Luthy DA, et al. 1990. Prenatal sonographic findings of Down syndrome: review of 94 cases. Obstet Gynecol 76: 370-377.
21. Nyberg DA, Resta RG, Luthy DA, et al. 1993a. Humerus and femur length shortening in the detection of Down's syndrome. Am J Obstet Gynecol 168: 534-538.
22. Nyberg DA, Dubinsky T, Resta RG, Mahoney BS, Hickok DE, Luthy DA. 1993b. Echogenic fetal bowel during the second trimester: clinical importance. Radiology 188: 527-531.
23. Pinette MG, Egan JF, Wax JR, Blackstone J, Cartin A, Benn PA. 2003. Combined sonographic and biochemical markers for Down syndrome screening. J Ultrasound Med 22: 1185-1190.
24. Shipp TD, Bromley B, Lieberman E, et al. 2000. The frequency of the detection of fetal echogenic intracardiac foci with respect to maternal race. Ultrasound Obstet Gynecol 15: 460-462.
25. Smith-Bindman R, Hosmer W, Feldstein VA, Deeks JJ, Goldberg JD. 2001. Second-trimester ultrasound to detect fetuses with Down syndrome: a meta-analysis. JAMA 285: 1044-1055.
26. Wald NJ, Watt HC, Hackshaw AK. 1999. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med 341: 461-467.
27. Wapner R, Thom E, Simpson JL, et al. 2003. First-trimester screening for trisomies 21 and 18. N Engl J Med 349: 1405-1413.
28. Winter TC, Anderson AM, Cheng EY, et al. 2000a. Echogenic intracardiac focus in 2nd-trimester fetuses with trisomy 21: usefulness as a US marker. Radiology 216: 450-456.
29. Winter TC, Uhrich SB, Souter VL, et al. 2000b. The "genetic sonogram": comparison of the index scoring system with the age-adjusted US risk assessment. Radiology 215(3): 775-782.
30. Yeo L, Vintzileos AM. 2003. The use of genetic sonography to reduce the need for amniocentesis in women at high-risk for Down syndrome. Semin Perinatol 27: 152-159.